JP2022512643A5 - - Google Patents

Info

Publication number
JP2022512643A5
JP2022512643A5 JP2021519602A JP2021519602A JP2022512643A5 JP 2022512643 A5 JP2022512643 A5 JP 2022512643A5 JP 2021519602 A JP2021519602 A JP 2021519602A JP 2021519602 A JP2021519602 A JP 2021519602A JP 2022512643 A5 JP2022512643 A5 JP 2022512643A5
Authority
JP
Japan
Prior art keywords
unsubstituted
substituted
nhc
nhnh
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021519602A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512643A (ja
JP7631191B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/055461 external-priority patent/WO2020076996A1/en
Publication of JP2022512643A publication Critical patent/JP2022512643A/ja
Publication of JP2022512643A5 publication Critical patent/JP2022512643A5/ja
Priority to JP2025017433A priority Critical patent/JP2025072508A/ja
Application granted granted Critical
Publication of JP7631191B2 publication Critical patent/JP7631191B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021519602A 2018-10-09 2019-10-09 E3リガーゼの共有結合による標的化 Active JP7631191B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025017433A JP2025072508A (ja) 2018-10-09 2025-02-05 E3リガーゼの共有結合による標的化

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862743337P 2018-10-09 2018-10-09
US62/743,337 2018-10-09
PCT/US2019/055461 WO2020076996A1 (en) 2018-10-09 2019-10-09 Covalent targeting of e3 ligases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025017433A Division JP2025072508A (ja) 2018-10-09 2025-02-05 E3リガーゼの共有結合による標的化

Publications (3)

Publication Number Publication Date
JP2022512643A JP2022512643A (ja) 2022-02-07
JP2022512643A5 true JP2022512643A5 (enExample) 2022-10-18
JP7631191B2 JP7631191B2 (ja) 2025-02-18

Family

ID=70164411

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021519602A Active JP7631191B2 (ja) 2018-10-09 2019-10-09 E3リガーゼの共有結合による標的化
JP2025017433A Pending JP2025072508A (ja) 2018-10-09 2025-02-05 E3リガーゼの共有結合による標的化

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025017433A Pending JP2025072508A (ja) 2018-10-09 2025-02-05 E3リガーゼの共有結合による標的化

Country Status (5)

Country Link
US (2) US12161648B2 (enExample)
EP (1) EP3863642A4 (enExample)
JP (2) JP7631191B2 (enExample)
CN (2) CN120468320A (enExample)
WO (1) WO2020076996A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11666661B2 (en) 2018-03-23 2023-06-06 The Regents Of The University Of California Methods and compounds for targeted autophagy
GB202005876D0 (en) * 2020-04-22 2020-06-03 Univ Dundee Protein degradation
CN116057042B (zh) * 2020-07-30 2024-10-18 赛诺菲 丙烯酰胺取代的茚满化合物及其治疗用途
CN117042765A (zh) * 2021-01-08 2023-11-10 德克萨斯大学系统董事会 印苦楝内酯类似物及其使用方法
WO2022150667A1 (en) * 2021-01-08 2022-07-14 The Board Of Regents Of The University Of Texas System Nimbolide analogs and methods of use thereof
US20250276069A1 (en) * 2021-03-04 2025-09-04 The Scripps Research Institute Heterobifunctional compositions for targeted protein degradation and methods for their use
EP4313979A4 (en) 2021-03-25 2025-02-19 Technion Research & Development Foundation Limited RNF4-TARGETED COMPOUNDS AND USES THEREOF
CN113527270B (zh) * 2021-07-16 2024-03-01 河南大学 一种靶向单酰基甘油脂肪酶的protac分子的医药中间体、制备方法及应用
CN116676273A (zh) * 2022-02-22 2023-09-01 中国科学院深圳先进技术研究院 一种蛋白水解靶向流感病毒及其制备方法和应用
CN114560908B (zh) * 2022-03-11 2024-10-25 国家纳米科学中心 一种多肽protac分子及其制备方法和应用
WO2023209651A1 (en) * 2022-04-29 2023-11-02 Dong-A St Co., Ltd. Bicycle compounds as tead inhibitor
CN115417913B (zh) * 2022-08-26 2024-10-29 天津医科大学 靶向雌激素受体的谷胱甘肽响应protac降解剂的制备方法及应用
JP2025533275A (ja) * 2022-10-13 2025-10-03 ハンミ ファーマシューティカルズ カンパニー リミテッド Yap-tead相互作用を阻害するための新規なヘテロ二環式化合物及びそれを含む薬学的組成物
EP4605088A1 (en) * 2022-10-21 2025-08-27 Novartis AG Molecular glue degrader compounds and uses thereof
CN117263865B (zh) * 2023-08-04 2026-03-27 南开大学 以6,6-二甲基双环[3.1.1]-2-甲胺为疏水基团的蛋白降解剂及其制备方法、药物组合物和应用
WO2025226951A1 (en) * 2024-04-24 2025-10-30 Novartis Ag Molecular glue degrader compounds and uses thereof
CN119331047B (zh) * 2024-10-09 2025-09-30 重庆医科大学 一种蛋白水解靶向嵌合体及其制备方法
CN119405823B (zh) * 2024-11-15 2025-10-21 湖南大学 一种基于g四链体rna的蛋白降解靶向嵌合体及其制备方法与应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2443370A1 (en) * 2002-10-17 2004-04-17 Mount Sinai Hospital Structures of substrate binding pockets of scf complexes
KR100874209B1 (ko) * 2007-08-17 2008-12-15 한국화학연구원 3,10-다이하이드로-1H-[1,4]다이아제피노[5,6-b]인돌-2-온 유도체 및 약학적으로 허용 가능한 염, 그의 제조방법및 그의 용도
GB0725214D0 (en) * 2007-12-24 2008-02-06 Karobio Ab Pharmaceutical compounds
ES2606958T3 (es) * 2010-05-14 2017-03-28 Dana-Farber Cancer Institute, Inc. Compuestos de tienotriazolodiazepina para tratar una neoplasia
CN101928747B (zh) 2010-08-31 2012-08-08 中国人民解放军第二军医大学 E3泛素连接酶chip在脑胶质瘤疾病中的应用
WO2013170147A1 (en) * 2012-05-11 2013-11-14 Yale University Compounds useful for promoting protein degradation and methods using same
KR101497979B1 (ko) * 2013-02-04 2015-03-03 서울대학교산학협력단 인돌 유도체 및 이를 포함하는 rage 관련 질환의 예방 또는 치료용 약학적 조성물
WO2015035199A1 (en) * 2013-09-06 2015-03-12 Mayo Foundation For Medical Education And Research Neem compositions used for the treatment of cancer
US20180228907A1 (en) 2014-04-14 2018-08-16 Arvinas, Inc. Cereblon ligands and bifunctional compounds comprising the same
CN104017879A (zh) * 2014-06-16 2014-09-03 山东大学 Fbxo31基因及其相关产物在制备胃癌诊断试剂中的应用
RU2761564C9 (ru) * 2015-05-29 2022-03-17 Дзе Трастиз Оф Дзе Юнивёрсити Оф Пенсильвания Композиции и способы деградации неправильно упакованных белков
CR20180336A (es) 2015-11-25 2018-08-06 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos
AU2017250076B2 (en) * 2016-04-12 2021-07-22 The Regents Of The University Of Michigan Bet protein degraders
CA3036834A1 (en) 2016-09-13 2018-03-22 The Regents Of The University Of Michigan Fused 1,4-oxazepines as bet protein degraders
US20200054651A1 (en) * 2017-02-03 2020-02-20 The Regents Of The University Of California Compositions and methods for modulating ppp2r1a
SG11201906671SA (en) * 2017-02-03 2019-08-27 Univ California Compositions and methods for inhibiting reticulon 4
WO2018144869A1 (en) * 2017-02-03 2018-08-09 The Regents Of The University Of California Compositons and methods for modulating uba5
WO2020146779A1 (en) 2019-01-11 2020-07-16 The Regents Of The University Of California mTORC1 INHIBITORS FOR ACTIVATING AUTOPHAGY

Similar Documents

Publication Publication Date Title
JP2025500430A5 (enExample)
JP2024040167A5 (enExample)
RU2019105534A (ru) Модуляторы хемокинового рецептора и их применение
JP2022549510A5 (enExample)
JP2022516684A5 (enExample)
JP2023171659A5 (enExample)
JP2022553702A5 (enExample)
JP2020114818A5 (enExample)
JP2021510696A5 (enExample)
JP2022554094A5 (enExample)
JP2022533069A5 (enExample)
JP2020518673A5 (enExample)
CN111565757A (zh) 包含生物活性化合物的磷酸烷基聚合物
JP2020530007A5 (enExample)
JP2023529099A5 (enExample)
CN111465608A (zh) 包含生物学活性化合物的离子型聚合物
JP2020518669A5 (enExample)
JP2025509286A5 (enExample)
JP2023531252A5 (enExample)
JP2017528498A5 (enExample)
JP2009536178A5 (enExample)
JP2024510267A5 (enExample)
JP2022504762A5 (enExample)
JP2024501537A5 (enExample)
JP2017511795A5 (enExample)